ClinVar Miner

Submissions for variant NM_001918.5(DBT):c.327C>T (p.Thr109=)

gnomAD frequency: 0.00078  dbSNP: rs138796800
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000192508 SCV000247160 uncertain significance not specified 2014-06-27 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000322581 SCV000346208 uncertain significance Maple syrup urine disease 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
GeneDx RCV000756009 SCV000523248 likely benign not provided 2018-05-24 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000756009 SCV000883705 likely benign not provided 2018-04-20 criteria provided, single submitter clinical testing The c.327C>T; p.Thr109Thr variant (rs138796800, ClinVar variant ID 210824) does not alter the amino acid sequence of the DBT protein and computational splice site prediction algorithms do not predict a change in the nearest splice site or creation of a cryptic splice site. This variant has not been reported in association with mitochondrial disease in medical literature or in gene specific variation databases. This variant is listed in the genome Aggregation Database (gnomAD) with a South Asian population frequency of 0.2% (identified on 56 out of 30,774 chromosomes, including one homozygote). Based on the available information, the c.327C>T variant is likely to be benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV000322581 SCV001014405 likely benign Maple syrup urine disease 2024-01-29 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000756009 SCV001745935 likely benign not provided 2023-02-01 criteria provided, single submitter clinical testing DBT: BP4, BP7
Clinical Genetics, Academic Medical Center RCV000192508 SCV001921715 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000756009 SCV001929099 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000756009 SCV001968435 likely benign not provided no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003917747 SCV004735696 likely benign DBT-related disorder 2019-10-28 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.